Literature DB >> 8089419

[Prevalence of ophthalmopathy in Basedow disease. Follow-up of patients one year following diagnosis of hyperthyroidism].

O Vangheluwe1, A Ducasse, C Vaudrey, B Maes, M J Delisle.   

Abstract

During a study performed to estimate the prevalence and evolution of ophthalmologic symptoms in Graves' disease, we examined 85 patients suffering from diffuse hyperfunctional goiter, which was recently discovered. Forty-seven of these patients came back to the one year ophthalmologic control examination. The patients classed 1 in the Nospecs at first examination rarely remained in the same class either worsening or ameliorating. The worsening or amelioration were independent from the treatment employed for hyperthyroidism and from the results of this treatment. The patients classed 0 in the Nospecs mostly remained in the same class. The patients in which first examination discovered more severe signs and especially inflammatory signs (eyelid oedema for example) should be carefully followed up.

Entities:  

Mesh:

Year:  1994        PMID: 8089419

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  2 in total

1.  Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.

Authors:  Joshua D Stein; David Childers; Shivani Gupta; Nidhi Talwar; Bin Nan; Brian J Lee; Terry J Smith; Raymond Douglas
Journal:  JAMA Ophthalmol       Date:  2015-03       Impact factor: 7.389

2.  Association of Other Autoimmune Diseases With Thyroid Eye Disease.

Authors:  Mary Kelada; Parizad Avari; Soma Farag; Rashmi Akishar; Rajni Jain; Ahmad Aziz; Claire Feeney; Vassiliki Bravis; Karim Meeran; Vickie Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-05       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.